Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Clinical trial NCT07216235 · RECRUITING
Trial details
- NCT number
- NCT07216235
- Sponsor
- Zydus Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2032-11-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.